ARCHIVES

Phase III Cyramza Trial Meets OS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

NCI New Advisory Group Named On special Populations

June 25, 1999

Science Policy: Silicone Breast Implants Don’t Cause Disease

June 25, 1999

DCE Advisors Approve New Epidemiology RFPs Table Proposed RFA

April 16, 1993

NCI Publishes Report On Pancreatic Cancer

March 7, 2014

Interferon “Hysteria” Prompts ASCO To Warn Against Expecting Immediate Benefits

June 20, 1980

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

February 22, 2013